Hunan Sterol pharmaceutical Co., Ltd

This study observed and investigated the single oral administration of the test preparation dienogest tablets (specification: 1 mg, produced by Hunan Chunjian Pharmaceutical Technology Co., Ltd.) and the reference preparation dienogest tablets (specification: 1 mg, produced by Mochida Seiki Co., Ltd. ) in Chinese adult healthy subjects, and evaluate the bioequivalence of the two oral preparations in fasting and postprandial states.

This study investigated the pharmacokinetic characteristics of ursodeoxycholic acid capsules (test preparation, specification: 250 mg) provided by Hunan Chunjian Pharmaceutical Technology Co., Ltd. and ursodeoxycholic acid capsules (reference preparation, trade name: Ursofol®, specification: 250 mg) produced by Dr. Falk Pharma GmbH and licensed by Losan Pharma GmbH, respectively, when taken orally as a single dose in healthy subjects under fasting and postprandial conditions, and evaluated the bioequivalence and safety of the two preparations.

This study investigated the pharmacokinetic characteristics of a single oral dose of dienogest tablets (test preparation, strength: 2 mg) produced by Hunan Chunjian Pharmaceutical Technology Co., Ltd. or dienogest tablets (reference preparation, trade name: Visanne®, strength: 2 mg) licensed by Jenapharm GmbH & Co. KG (produced by Bayer Weimar GmbH und Co. KG) in healthy female subjects under fasting and postprandial conditions, and evaluated the bioequivalence and safety of the two preparations.